What's new

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Apr 15, 2025 - 16:08
 0
Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Honda May Move More Production To U.S. In Tariff Response

Next Article

FERC should order PJM to rerun last capacity auction: ratepayer advocates

Related Posts

EMEA-003512-PIP01-23

EMEA-003512-PIP01-23

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0